Health News

Hepatitis C May Affect Millions of Americans
Although there are medications that can cure hepatitis C, an estimated 2.4 million Americans are living with the disease, according to a new report from the Centers for Disease Control and Prevention (CDC).
HIV and the Hepatitis B Vaccine
Many people who have HIV may not receive the hepatitis B vaccine, according to a new study.
A Shorter Treatment for Hepatitis C
The US Food and Drug Administration (FDA) has approved a new treatment for chronic hepatitis C virus infection.
New Hepatitis Rx Approved
The US Food and Drug Administration (FDA) has approved a new medication to treat hepatitis.
New Options for Children with Hep C
The US Food and Drug Administration (FDA) has approved two medications to treat children with hepatitis C.
New Hep B Treatment Gets Green Light
The US Food and Drug Administration has approved a new medication to treat hepatitis B. 
FDA: Risk Tied to Some Antiviral Medications
The US Food and Drug Administration (FDA) has issued a warning about the potential for hepatitis B virus (HBV) reactivation with the use of certain antivirals.
A Four-in-One Hit to Hep C
The US Food and Drug Administration has approved a tablet that contains four medications in one tablet to treat hepatitis C.
New Hepatitis C Rx Approved
The US Food and Drug Administration (FDA) has approved a new hepatitis C medication.
FDA Expands Label for Daklinza
On February 5, 2016, FDA approved changes to the DAKLINZA(daclatasvir) label to expand the indication to include HCV genotype 1 infection and expand dosage recommendations to the following populations and to revise dosage recommendations for HCV genotype 3 subjects with compensated (Child-Pugh A) cirrhosis: